Susquehanna International Group
CSBR icon

Susquehanna International Group’s Champions Oncology CSBR Stock Holding History

Susquehanna International Group’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,811
Closed -$128K – 12526
2025
Q3 		$128K Sell
19,811
-14,119
-42% -$99.5K ﹤0.01% 11403
2025
Q2 		$250K Sell
33,930
-92,600
-73% -$653K ﹤0.01% 10737
2025
Q1 		$1.1M Buy
126,530
+115,006
+998% +$1.17M ﹤0.01% 7008
2024
Q4 		$98.8K Buy
+11,524
New +$58K ﹤0.01% 11358
2019
Q3 		– Sell
-24,510
Closed -$192K – 10238
2019
Q2 		$192K Buy
24,510
+8,279
+51% +$72.6K ﹤0.01% 9159
2019
Q1 		$159K Buy
+16,231
New +$162K ﹤0.01% 8008
2018
Q4 		– Sell
-10,214
Closed -$178K – 9054
2018
Q3 		$178K Buy
+10,214
New +$91K ﹤0.01% 8307

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group's CSBR Position: Q4 2025 in Review

Susquehanna International Group sold out of Champions Oncology (CSBR) in Q4 2025, closing a stake of 19,811 shares — an estimated $128K sold.

Susquehanna International Group first reported a position in CSBR in Q3 2018 and held it in 7 quarters. The position peaked at $1.1M in Q1 2025. 27 funds tracked by Wall St. Rank hold CSBR as of Q4 2025.

  • Susquehanna International Group reported no remaining Champions Oncology position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 19,811 Champions Oncology shares in Q4 2025, an estimated $128K.
  • Susquehanna International Group first reported a position in Champions Oncology in Q3 2018 and held it in 7 quarters.
  • Susquehanna International Group's Champions Oncology position peaked at $1.1M in Q1 2025.
  • 27 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.